News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
720,433 Results
Type
Article (49057)
Company Profile (308)
Press Release (671068)
Section
Business (211965)
Career Advice (2076)
Deals (36475)
Drug Delivery (92)
Drug Development (83341)
Employer Resources (169)
FDA (16886)
Job Trends (15659)
News (358571)
Policy (34589)
Tag
Academia (2758)
Alliances (51210)
Alzheimer's disease (1266)
Approvals (16798)
Artificial intelligence (126)
Bankruptcy (364)
Best Places to Work (11917)
Biotechnology (212)
Breast cancer (110)
Cancer (930)
Cardiovascular disease (85)
Career advice (1742)
Cell therapy (200)
Clinical research (65798)
Collaboration (331)
Compensation (168)
COVID-19 (2648)
Data (861)
Diabetes (136)
Diagnostics (6304)
Drug pricing (82)
Earnings (86217)
Employer resources (147)
Events (113697)
Executive appointments (248)
FDA (17333)
Funding (294)
Gene therapy (151)
GLP-1 (604)
Government (4586)
Healthcare (19727)
Infectious disease (2724)
Inflammatory bowel disease (106)
Interviews (316)
IPO (16627)
Job creations (4037)
Job search strategy (1494)
Layoffs (425)
Legal (8401)
Lung cancer (161)
Manufacturing (153)
Medical device (14137)
Medtech (14142)
Mergers & acquisitions (19849)
Metabolic disorders (381)
Neuroscience (1516)
NextGen Class of 2024 (6894)
Non-profit (4721)
Northern California (1197)
Obesity (230)
Opinion (190)
Patents (95)
People (58937)
Phase I (20389)
Phase II (28907)
Phase III (21641)
Pipeline (208)
Postmarket research (2731)
Preclinical (8707)
Radiopharmaceuticals (244)
Rare diseases (184)
Real estate (6285)
Regulatory (22835)
Research institute (2469)
Resumes & cover letters (359)
Southern California (1082)
Startups (3815)
United States (11792)
Vaccines (573)
Weight loss (179)
Date
Today (84)
Last 7 days (737)
Last 30 days (2757)
Last 365 days (36547)
2024 (30967)
2023 (41144)
2022 (52382)
2021 (57103)
2020 (55916)
2019 (48798)
2018 (36939)
2017 (33748)
2016 (33564)
2015 (39609)
2014 (33324)
2013 (28558)
2012 (30846)
2011 (31551)
2010 (29924)
Location
Africa (789)
Arizona (194)
Asia (40146)
Australia (6606)
California (2715)
Canada (1169)
China (212)
Colorado (124)
Connecticut (127)
Europe (86781)
Florida (390)
Georgia (106)
Illinois (333)
Indiana (180)
Kansas (98)
Maryland (536)
Massachusetts (2228)
Michigan (145)
Minnesota (256)
New Jersey (827)
New York (838)
North Carolina (713)
Northern California (1197)
Ohio (125)
Pennsylvania (743)
South America (1180)
Southern California (1082)
Texas (388)
Utah (81)
Washington State (327)
720,433 Results for "aerin medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
New Two-Year Results Show Sustained Improvement in Chronic Rhinitis Symptoms Following a Single Procedure with Aerin Medical’s RhinAer®
Aerin Medical Inc. today announced the publication of positive 24-month results from RHINTRAC, a randomized, sham-controlled clinical trial, in the International Forum of Allergy & Rhinology (IFAR).
February 29, 2024
·
5 min read
Biotech Bay
Aerin Medical Announces Positive Two-year Outcomes from the VATRAC Trial of VivAer®
Aerin Medical Announces Positive Two-year Outcomes from the VATRAC Trial of VivAer .
February 8, 2024
·
5 min read
Business
Derrick Sung Joins Aerin Medical as Chief Financial Officer
Aerin Medical Inc., a company dedicated to providing Ear, Nose and Throat physicians with non-invasive solutions for the treatment of chronic nasal conditions, announced that Derrick Sung has been appointed chief financial officer of the company.
November 20, 2023
·
3 min read
Biotech Bay
Aerin Medical Announces Sustained Clinical and Quality-of-Life Improvements Two Years After Chronic Rhinitis Treatment with RhinAer®
Aerin Medical Announces Sustained Clinical and Quality-of-Life Improvements Two Years After Chronic Rhinitis Treatment with RhinAer ®.
December 5, 2023
·
5 min read
Biotech Bay
Aerin Medical Announces Advances for Chronic Rhinitis Treatment with New CPT® Code and Final CMS-Established Payment Rates
Aerin Medical Inc. announced that the Centers for Medicare and Medicaid Services assigned payment for a new Category I Current Procedural Terminology code for endoscopic destruction of the posterior nasal nerve using radiofrequency ablation.
November 3, 2023
·
4 min read
Biotech Bay
Aerin Medical Announces New Positive Two-Year Results from VivAer® AERWAY Study
Aerin Medical Inc. today announced the publication of positive two-year follow-up data from the AERWAY trial for patients with severe or extreme nasal airway obstruction (NAO) due to nasal valve collapse (NVC).
July 13, 2023
·
6 min read
Biotech Bay
Aerin Medical Supports AAO-HNS Position Recognizing Nasal Valve Repair as a Distinct Procedure that Improves Nasal Obstruction Symptoms
Aerin Medical Inc., a company dedicated to providing Ear, Nose and Throat (ENT) physicians with non-invasive solutions for the treatment of chronic nasal conditions, supports the recent American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) position statement.
April 18, 2023
·
4 min read
Biotech Bay
Aerin Medical Announces Establishment of a New CPT® Code for Endoscopic Destruction of the Posterior Nasal Nerve Using Radiofrequency Ablation
Aerin Medical Inc. announced that the American Medical Association Current Procedural Terminology Editorial Panel accepted the application for a new Category I CPT code to report endoscopic destruction of the posterior nasal nerve using radiofrequency ablation.
October 18, 2022
·
3 min read
Biotech Bay
Aerin Medical Secures $60 Million in Equity Financing
Aerin Medical Inc. a company dedicated to providing Ear, Nose and Throat (ENT) physicians with non-invasive solutions for the treatment of chronic nasal conditions, today announced it has recently closed a $60 million equity financing.
June 16, 2022
·
4 min read
Business
Avanos Medical, Inc. Appoints Indrani Franchini to Board of Directors
Avanos Medical, Inc. (NYSE: AVNS) today announced that Indrani Franchini has been appointed as a new independent member of the Avanos board of directors.
July 1, 2024
·
2 min read
1 of 72,044
Next
